WPA

Private medical Insurers (PMI) have endorsed the Office of Fair Trading referring the UK healthcare market to the Competition Commission and said they will take an active part in investigations.

Private Medical Insurance (PMI) provider WPA has released evidence the tax treatment of its Corporate Deductible schemes is sanctioned by the taxman.

Axa PPP has extended its cancer coverage to include the clinically effective prostate cancer drug rejected for the NHS because it is too expensive.

WPA has introduced moratorium underwriting on its individual private medical insurance (PMI) plans for clients who fit certain criteria.

Health insurers have applauded the Office of Fair Trading's (OFT) decision to refer the operation of the private healthcare market to the Competition Commission (CC).

With the medical insurance sector in a state of flux, Owain Thomas dons the white coat and protective glasses to scientifically investigate the issues.

Moving from blindly buying PMI to defining a healthcare strategy will stabilise company health plans. Rachel Riley explains.

Axa PPP's Fergus Craig has a keen eye on PMI. Paul Robertson asks him how the market is improving.

WPA has begun work with the first of a series of IFAs doing business through the insurer's franchisee network.

WPA is "freeing up" its group underwriting methods through greater use of automation, allowing instant quoting and real time data of who is on risk.